Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Radioimmunotherapy In Relapsed/Refractory Mantle Cell Lymphoma Patients: Final Results Of a European MCL Network Phase II Trial

Simone Ferrero, Alessandro Pastore, Roswitha Forstpointner, M.D., Christian W. Scholz, Antonio Pezzutto, Lothar Bergmann, Lorenz Truemper, Juergen Finke, Ulrich Keller, Marco Ladetto, Wolfgang Hiddemann, M.D., Oliver Weigert, Michael Unterhalt, Martin Dreyling

Blood (2013) 122 (21): 4384.

https://doi.org/10.1182/blood.V122.21.4384.4384

Published: 2013

Journal Articles

Fludarabine Versus Fludarabine Plus Epirubicin in the Treatment of Chronic Lymphocytic Leukemia - Final Results of a German Randomized Phase-III Study.

Mathias J. Rummel, Stephan Stilgenbauer, Heinold Gamm, Andreas Rost, Doehner Hartmut, Dieter Hoelzer, Lothar Bergmann

Blood (2005) 106 (11): 2123.

https://doi.org/10.1182/blood.V106.11.2123.2123

Published: 2005

Journal Articles

Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-κB/Rel–regulated inhibitors of apoptosis

Gerd Munzert, Dieter Kirchner, Heike Stobbe, Lothar Bergmann, Roland M. Schmid, Hartmut Döhner, Hermann Heimpel

Blood (2002) 100 (10): 3749–3756.

https://doi.org/10.1182/blood.V100.10.3749

Published: 2002

Journal Articles

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Donald Bunjes, Inga Buchmann, Christian Duncker, Ulrike Seitz, Jörg Kotzerke, Markus Wiesneth, Dagmar Dohr, Martin Stefanic, Andreas Buck, Stefanie V. Harsdorf, Gerhard Glatting, Wolfgang Grimminger, Tunca Karakas, Gerd Munzert, Hartmut Döhner, Lothar Bergmann, Sven N. Reske

Blood (2001) 98 (3): 565–572.

https://doi.org/10.1182/blood.V98.3.565

Published: 2001

Journal Articles

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Christoph W. M. Reuter, Michael A. Morgan, Lothar Bergmann

Blood (2000) 96 (5): 1655–1669.

https://doi.org/10.1182/blood.V96.5.1655

Published: 2000

Journal Articles

Wilms Tumor Gene (wt1) mRNA Is Equally Expressed in Blast Cells From Acute Myeloid Leukemia and Normal CD34 + Progenitors

Ulrich Maurer, Eckhart Weidmann, Tunca Karakas, Dieter Hoelzer, Lothar Bergmann

Blood (1997) 90 (10): 4230–4232.

https://doi.org/10.1182/blood.V90.10.4230

Published: 1997

Journal Articles

High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome

Lothar Bergmann, Cornelius Miething, Ulrich Maurer, Jürgen Brieger, Tunca Karakas, Eckhart Weidmann, Dieter Hoelzer

Blood (1997) 90 (3): 1217–1225.

https://doi.org/10.1182/blood.V90.3.1217

Published: 1997

NARROW

Radioimmunotherapy In Relapsed/Refractory Mantle Cell Lymphoma Patients: Final Results Of a European MCL Network Phase II Trial

Fludarabine Versus Fludarabine Plus Epirubicin in the Treatment of Chronic Lymphocytic Leukemia - Final Results of a German Randomized Phase-III Study.

Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-κB/Rel–regulated inhibitors of apoptosis

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Wilms Tumor Gene (wt1) mRNA Is Equally Expressed in Blast Cells From Acute Myeloid Leukemia and Normal CD34 + Progenitors

High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome

Email alerts

ASH Publications

American Society of Hematology

Radioimmunotherapy In Relapsed/Refractory Mantle Cell Lymphoma Patients: Final Results Of a European MCL Network Phase II Trial

Fludarabine Versus Fludarabine Plus Epirubicin in the Treatment of Chronic Lymphocytic Leukemia - Final Results of a German Randomized Phase-III Study.

Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-κB/Rel–regulated inhibitors of apoptosis

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Wilms Tumor Gene (wt1) mRNA Is Equally Expressed in Blast Cells From Acute Myeloid Leukemia and Normal CD34 + Progenitors

High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only